Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss.

clinical research/practice complication: surgical/technical donors and donation: donation after circulatory determination of death (DCD) extracorporeal membrane oxygenation (ECMO) ischemia reperfusion injury (IRI) liver transplantation/hepatology organ procurement and allocation

Journal

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638

Informations de publication

Date de publication:
04 2022
Historique:
revised: 11 11 2021
received: 29 07 2021
accepted: 11 11 2021
pubmed: 3 12 2021
medline: 6 4 2022
entrez: 2 12 2021
Statut: ppublish

Résumé

Postmortem normothermic regional perfusion (NRP) is a rising preservation strategy in controlled donation after circulatory determination of death (cDCD). Herein, we present results for cDCD liver transplants performed in Spain 2012-2019, with outcomes evaluated through December 31, 2020. Results were analyzed retrospectively and according to recovery technique (abdominal NRP [A-NRP] or standard rapid recovery [SRR]). During the study period, 545 cDCD liver transplants were performed with A-NRP and 258 with SRR. Median donor age was 59 years (interquartile range 49-67 years). Adjusted risk estimates were improved with A-NRP for overall biliary complications (OR 0.300, 95% CI 0.197-0.459, p < .001), ischemic type biliary lesions (OR 0.112, 95% CI 0.042-0.299, p < .001), graft loss (HR 0.371, 95% CI 0.267-0.516, p < .001), and patient death (HR 0.540, 95% CI 0.373-0.781, p = .001). Cold ischemia time (HR 1.004, 95% CI 1.001-1.007, p = .021) and re-transplantation indication (HR 9.552, 95% CI 3.519-25.930, p < .001) were significant independent predictors for graft loss among cDCD livers with A-NRP. While use of A-NRP helps overcome traditional limitations in cDCD liver transplantation, opportunity for improvement remains for cases with prolonged cold ischemia and/or technically complex recipients, indicating a potential role for complimentary ex situ perfusion preservation techniques.

Identifiants

pubmed: 34856070
doi: 10.1111/ajt.16899
pii: S1600-6135(22)08175-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1169-1181

Informations de copyright

© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.

Références

Thuong M, Ruiz A, Evrard P, et al. New classification of donation after circulatory death donors definitions and terminology. Transpl Int. 2016;29(7):749-759.
Domínguez-Gil B, Delmonico FL, Shaheen FAM, et al. The critical pathway for deceased donation: Reportable uniformity in the approach to deceased donation. Transpl Int. 2011;24(4):373-378.
Paterno F, Guarrera JV, Wima K, et al. Clinical implications of donor warm and cold ischemia time in donor after circulatory death liver transplantation. Liver Transplant. 2019;25(9):1342-1352.
Kohli DR, Harrison ME, Adike AO, et al. Predictors of biliary strictures after liver transplantation among recipients of DCD (donation after cardiac death) grafts. Dig Dis Sci. 2019;64(7):2024-2030. 10.1007/s10620-018-5438-0
Farid SG, Attia MS, Vijayanand D, et al. Impact of donor hepatectomy time during organ procurement in donation after circulatory death liver transplantation: the United Kingdom experience. Transplantation. 2019;103(4):E79-88.
Croome KP, Mathur AK, Lee DD, et al. Outcomes of donation after circulatory death liver grafts from donors 50 years or older. Transplantation. 2018;102(7):1108-1114. http://insights.ovid.com/crossref?an=00007890-900000000-96670
Schlegel A, Kalisvaart M, Scalera I, et al. The UK DCD risk score: a new proposal to define futility in donation-after-circulatory-death liver transplantation. J Hepatol. 2018;68(3):456-464. 10.1016/j.jhep.2017.10.034
Schlegel A, Scalera I, Perera MTPR, et al. Impact of donor age in donation after circulatory death liver transplantation: is the cutoff “60” still of relevance? Liver Transplant. 2018;24(3):352-362. https://onlinelibrary.wiley.com/doi/abs/ 10.1002/lt.24865
Mihaylov P, Mangus R, Ekser B, et al. Expanding the donor pool with the use of extended criteria donation after circulatory death livers. Liver Transplant. 2019;25(8):lt.25462. https://onlinelibrary.wiley.com/doi/abs/ 10.1002/lt.25462
Hessheimer AJ, Coll E, Torres F, et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. J Hepatol. 2019;70(4):658-665. 10.1016/j.jhep.2018.12.013
Watson CJE, Hunt F, Messer S, et al. In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival. Am J Transplant. 2019;19(6):1745-1758. https://onlinelibrary.wiley.com/doi/abs/ 10.1111/ajt.15241
Hagness M, Foss S, Sørensen DW, et al. Liver transplant after normothermic regional perfusion from controlled donors after circulatory death: the norwegian experience. Transplant Proc. 2019;51(2):475-478. 10.1016/j.transproceed.2019.01.066
Muller X, Mohkam K, Mueller M, et al. Hypothermic oxygenated perfusion versus normothermic regional perfusion in liver transplantation from controlled donation after circulatory death: first international comparative study. Ann Surg. 2020;272(5):751-758.
Ruiz P, Gastaca M, Bustamante FJ, et al. Favorable outcomes after liver transplantation with normothermic regional perfusion from donors after circulatory death. Transplantation. 2019;103(5):938-943. http://insights.ovid.com/crossref?an = 00007890-900000000-96433
De Carlis R, Schlegel A, Frassoni S, et al. How to preserve liver grafts from circulatory death with long warm ischemia? A retrospective Italian cohort study with normothermic regional perfusion and hypothermic oxygenated perfusion. Transplantation. 2021;105(11):2385-2396.
Padilla M, Coll E, Fernández-Pérez C, et al. Improved short-term outcomes of kidney transplants in controlled donation after the circulatory determination of death with the use of normothermic regional perfusion. Am J Transplant. 2021;ajt.16622. https://onlinelibrary.wiley.com/doi/ 10.1111/ajt.16622
Hessheimer AJ, Riquelme F, Fundora-Suárez Y, García Pérez R, Fondevila C. Normothermic perfusion and outcomes after liver transplantation. Transplant Rev. 2019;33:200-208.
Hessheimer AJ, Billault C, Barrou B, Fondevila C. Hypothermic or normothermic abdominal regional perfusion in high-risk donors with extended warm ischemia times: impact on outcomes? Transpl Int. 2015;28(6):700-707. http://www.ncbi.nlm.nih.gov/pubmed/24797796
Net M, Valero R, Almenara R, et al. Hepatic xanthine levels as viability predictor of livers procured from non-heart-beating donor pigs. Transplantation. 2001;71(9):1232-1237. http://www.ncbi.nlm.nih.gov/pubmed/11397955
Net M, Valero R, Almenara R, et al. The effect of normothermic recirculation is mediated by ischemic preconditioning in NHBD liver transplantation. Am J Transplant. 2005;5(10):2385-2392. http://www.ncbi.nlm.nih.gov/pubmed/16162186
Kerforne T, Allain G, Giraud S, et al. Defining the optimal duration for normothermic regional perfusion in the kidney donor: a porcine preclinical study. Am J Transplant. 2019;19(3):737-751. https://onlinelibrary.wiley.com/doi/abs/ 10.1111/ajt.15063
DONACIÓN EN ASISTOLIA EN ESPAÑA : SITUACIÓN ACTUAL Y RECOMENDACIONES, Documento de Consenso Nacional de la Organización Nacional de Trasplantes. http://www.ont.es/infesp/DocumentosDeConsenso/DONACI%C3%93N%20EN%20ASISTOLIA%20EN%20ESPA%C3%91A.%20SITUACI%C3%93N%20ACTUAL%20Y%20RECOMENDACIONES.pdf. Published 2012. Accessed June 1, 2021.
Royal Decree 1723/2012, December 28, 2012, Annex I, Section 3: diagnosis of death based on circulatory and respiratory criteria. https://www.boe.es/eli/es/rd/2012/12/28/1723/con. Published 2012. Accessed June 1, 2021.
Lomero M, Gardiner D, Coll E, et al. Donation after circulatory death today: an updated overview of the European landscape. Transpl Int. 2020;33(1):76-88. https://onlinelibrary.wiley.com/doi/abs/ 10.1111/tri.13506
Jochmans I, Hessheimer AJ, Neyrinck A, et al. Consensus statement on normothermic regional perfusion in donation after circulatory death: report from the european society for organ transplantation’s transplant learning journey. Transpl Int. 2021.
Hessheimer AJ, Gastaca M, Miñambres E, et al. Donation after circulatory death liver transplantation: consensus statements from the Spanish liver transplantation society. Transpl Int. 2020;33(8):902-916.
Organización Nacional de Trasplantes. Protocolo Nacional de Donación y Trasplante Hepático en Donación en Asistolia Controlada. 2015.
Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16(8):943-949. http://www.ncbi.nlm.nih.gov/pubmed/20677285
Hessheimer AJ, Cárdenas A, García-Valdecasas JC, Fondevila C. Can we prevent ischemic-type biliary lesions in donation after circulatory determination of death liver transplantation? Liver Transplant. 2016;22(7):1025-1033. 10.1002/lt.24460
Croome KP, Mathur AK, Aqel B, et al. Classification of distinct patterns of ischemic cholangiopathy following DCD liver transplantation [published online ahead of print 2021]. Transplantation.
Muller X, Marcon F, Sapisochin G, et al. Defining benchmarks in liver transplantation: a multicenter outcome analysis determining best achievable results. Ann Surg. 2018;267(3):419-425.
Hessheimer AJ, Coll E, Ruíz P, et al. Reply to: “Normothermic regional perfusion - What is the benefit?”. J Hepatol. 2019;71(2):443-445. https://linkinghub.elsevier.com/retrieve/pii/S0168827819302661
Fondevila C, Hessheimer AJ, Maathuis M-HJ, et al. Superior preservation of DCD livers with continuous normothermic perfusion. Ann Surg. 2011;254(6):1000-1007. http://www.ncbi.nlm.nih.gov/pubmed/21862925
Doyle MBM, Collins K, Vachharajani N, et al. Outcomes using grafts from donors after cardiac death. J Am Coll Surg. 2015;221(1):142-152. http://www.ncbi.nlm.nih.gov/pubmed/26095563
de Vera ME, Lopez-Solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant. 2009;9(4):773-781. http://www.ncbi.nlm.nih.gov/pubmed/19344466
Skaro AI, Jay CL, Baker TB, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery. 2009;146(4):543-553; discussion 552-3. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2790600&tool=pmcentrez&rendertype=abstract
Heidenhain C, Pratschke J, Puhl G, et al. Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation. Transpl Int. 2010;23(1):14-22.
Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors. Ann Surg. 2011;253(4):817-825. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3103075&tool=pmcentrez&rendertype=abstract
Maroni L, Pinto C, Giordano DM, et al. Aging-related expression of twinfilin-1 regulates cholangiocyte biological response to injury. Hepatology. 2019;70(3):883-898.
Maeso-Díaz R, Ortega-Ribera M, Fernández-Iglesias A, et al. Effects of aging on liver microcirculatory function and sinusoidal phenotype. Aging Cell. 2018;17(6):1-14.
Hansen T, Hollemann D, Pitton MB, et al. Histological examination and evaluation of donor bile ducts received during orthotopic liver transplantation-a morphological clue to ischemic-type biliary lesion? Virchows Arch. 2012;461(1):41-48.
op den Dries S, Westerkamp AC, Karimian N, et al. Injury to peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures. J Hepatol. 2014;60(6):1172-1179.
de Jong IEM, Matton APM, van Praagh JB, et al. Peribiliary glands are key in regeneration of the human biliary epithelium after severe bile duct injury. Hepatology. 2019;69(4):1719-1734.
Mergental H, Laing RW, Kirkham AJ, et al. Transplantation of discarded livers following viability testing with normothermic machine perfusion. Nat Commun. 2020. 10.1038/s41467-020-16251-3
Muller X, Schlegel A, Würdinger M, et al. Can hypothermic oxygenated perfusion (HOPE) rescue futile DCD liver grafts? Hpb. 2019;21(9):1156-1165. 10.1016/j.hpb.2019.01.004
Epker JL, Bakker J, Lingsma HF, Kompanje EJO. An observational study on a protocol for withdrawal of life-sustaining measures on two non-academic intensive care units in the netherlands: few signs of distress, no suffering? J Pain Symptom Manage. 2015;50(5):676-684. 10.1016/j.jpainsymman.2015.05.017
Hessheimer AJ, Polak W, Antoine C, et al. Regulations and procurement surgery in DCD liver transplantation. Transplantation. 2021;Publish;Ah(5):945-951.
van Rijn R, Schurink IJ, de Vries Y, et al. Hypothermic machine perfusion in liver transplantation - a randomized trial. N Engl J Med. 2021;1-11. http://www.ncbi.nlm.nih.gov/pubmed/33626248
Trasplantes ON De Actividad de Donación y Trasplante Hepático España 2019. http://www.ont.es/infesp/Memorias/ACTIVIDAD%20DE%20DONACI%C3%93N%20%20TRASPLANTE%20ESPA%C3%91A%202019.pdf. Published 2019. Accessed June 1, 2021.
Brüggenwirth IMA, Werner MJM, Adam R, et al. The liver retransplantation risk score: a prognostic model for survival after adult liver retransplantation. Transpl Int. 2021;34(10):1928-1937.

Auteurs

Amelia J Hessheimer (AJ)

General & Digestive Surgery, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
General & Digestive Surgery Service, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, Barcelona, Spain.
IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.

Gloria de la Rosa (G)

Organización Nacional de Trasplantes, Madrid, Spain.

Mikel Gastaca (M)

Hospital Universitario Cruces, Bilbao, Spain.

Patricia Ruíz (P)

Hospital Universitario Cruces, Bilbao, Spain.

Alejandra Otero (A)

Complejo Hospitalario Universitario La Coruña, A Coruna, Spain.

Manuel Gómez (M)

Complejo Hospitalario Universitario La Coruña, A Coruna, Spain.

Felipe Alconchel (F)

Hospital Clínico Universitario Virgen de la Arrixaca, IMIB, El Palmar, Spain.

Pablo Ramírez (P)

Hospital Clínico Universitario Virgen de la Arrixaca, IMIB, El Palmar, Spain.

Andrea Bosca (A)

Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Rafael López-Andújar (R)

Hospital Universitario y Politécnico La Fe, Valencia, Spain.
CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.

Lánder Atutxa (L)

Hospital Universitario Donostia, San Sebastián, Spain.

Mario Royo-Villanova (M)

Hospital Clínico Universitario Virgen de la Arrixaca, IMIB, El Palmar, Spain.

Belinda Sánchez (B)

Hospital Regional Universitario de Málaga, Spain.

Julio Santoyo (J)

Hospital Regional Universitario de Málaga, Spain.

Luís M Marín (LM)

Hospital Universitario Virgen del Rocío, Seville, Spain.

Miguel Á Gómez-Bravo (MÁ)

Hospital Universitario Virgen del Rocío, Seville, Spain.

Fernando Mosteiro (F)

Complejo Hospitalario Universitario La Coruña, A Coruna, Spain.

María T Villegas Herrera (MT)

Hospital Universitario Virgen de las Nieves, Granada, Spain.

Jesús Villar Del Moral (J)

Hospital Universitario Virgen de las Nieves, Granada, Spain.

Carolina González-Abos (C)

General & Digestive Surgery Service, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, Barcelona, Spain.

Bárbara Vidal (B)

Hospital General Universitario de Castellón, Castellón, Spain.

Josefina López-Domínguez (J)

Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Spain.

Laura Lladó (L)

Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Spain.

José Roldán (J)

Hospital Universitario de Navarra, Pamplona, Spain.

Iago Justo (I)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Carlos Jiménez (C)

Hospital Universitario 12 de Octubre, Madrid, Spain.

Javier López-Monclús (J)

Hospital Universitario Puerta de Hierro, Majadahonda, Spain.

Víctor Sánchez-Turrión (V)

Hospital Universitario Puerta de Hierro, Majadahonda, Spain.

Gonzalo Rodríguez-Laíz (G)

Department of General & Digestive Surgery, ISABIAL, Hospital General Universitario de Alicante, Alicante, Spain.

Enrique Velasco Sánchez (E)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Jose Á López-Baena (JÁ)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Mireia Caralt (M)

Hospital Universitario Vall d'Hebrón, Barcelona, Spain.

Ramón Charco (R)

Hospital Universitario Vall d'Hebrón, Barcelona, Spain.

Santiago Tomé (S)

Complejo Hospitalario Universitario Santiago, Santiago de Compostela, Spain.

Evaristo Varo (E)

Complejo Hospitalario Universitario Santiago, Santiago de Compostela, Spain.

Pablo Martí-Cruchaga (P)

HPB and Liver Transplant Unit, General & Digestive Surgery, Clínica Universitaria de Navarra, Pamplona, Spain.

Fernando Rotellar (F)

HPB and Liver Transplant Unit, General & Digestive Surgery, Clínica Universitaria de Navarra, Pamplona, Spain.

María A Varona (MA)

Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.

Manuel Barrera (M)

Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.

Juan C Rodríguez-Sanjuan (JC)

Hospital Universitario Marqués de Valdecilla, Santander, Spain.

Javier Briceño (J)

Hospital Universitario Reina Sofía, Córdoba, Spain.

Diego López (D)

Hospital Universitario Infanta Cristina, Badajoz, Spain.

Gerardo Blanco (G)

Hospital Universitario Infanta Cristina, Badajoz, Spain.

Javier Nuño (J)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

David Pacheco (D)

Hospital Universitario Río Hortega, Valladolid, Spain.

Elisabeth Coll (E)

Organización Nacional de Trasplantes, Madrid, Spain.

Beatriz Domínguez-Gil (B)

Organización Nacional de Trasplantes, Madrid, Spain.

Constantino Fondevila (C)

General & Digestive Surgery, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
General & Digestive Surgery Service, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, Barcelona, Spain.
IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH